The requirements for laboratory balances in the pharmaceutical industry have undergone significant evolutions and changes in recent years. Driven by a general need for clarification and the goal of international harmonization, the major pharmacopeias — the United States Pharmacopeia (USP, chapters 41 & 1251), European Pharmacopeia (Ph.Eur.), Japanese Pharmacopeia (JP), and Chinese Pharmacopeia (ChP) — have all fundamentally revised their chapters on balances and brought them into closer alignment. At the heart of these changes is the recognition that the quality of analytical results depends critically on balance reliability.
Download this white paper from Sartorius to learn how laboratories can manage calibration, check performance, maintain environmental conditions, and confidently comply with these updated lab balance regulations
